new text begin Prohibition on use of step therapy protocols. new text end

new text begin A health plan that provides coverage for the treatment of stage four advanced metastatic cancer or associated conditions must not limit or exclude coverage for a drug approved by the United States Food and Drug Administration that is on the health plan's prescription drug formulary by mandating that an enrollee with stage four advanced metastatic cancer or associated conditions follow a step therapy protocol if the use of the approved drug is consistent with: new text end

new text begin (1) a United States Food and Drug Administration-approved indication; and new text end

new text begin (2) a clinical practice guideline published by the National Comprehensive Care Network. new text end